ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

36,633Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 1211

$1.45M Total Retail Price of All Prescriptions

Rank: 9 out of 1211

1,220 Patients Receiving at Least One Drug in Part D
97%Patients 65 Years and Older
36% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

1% of this provider’s 1,220 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

1% of this provider’s 35,984 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $65 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
METOPROLOL SUCCINATE 1,782 1,746 10 1 5
AMLODIPINE BESYLATE 1,709 1,683 2 2
SIMVASTATIN 1,497 1,475 3 1
ATENOLOL 1,445 1,425 4 13
LISINOPRIL 1,244 1,222 5 6
LOVASTATIN 977 954 6 37
CARVEDILOL 939 910 7 3
LOSARTAN POTASSIUM 807 796 8 12
CRESTOR 696 689 9 11
SPIRONOLACTONE 688 663 10 24
ATORVASTATIN CALCIUM 685 669 11 9
OMEPRAZOLE 677 671 12 20
FUROSEMIDE 648 646 13 7
RANITIDINE HCL 565 546 14 45
HYDROCHLOROTHIAZIDE 558 546 15 17
PRAVASTATIN SODIUM 547 545 16 18
BUMETANIDE 528 526 17 71
METFORMIN HCL 523 519 18 27
LOSARTAN-HYDROCHLOROTHIAZIDE 499 499 19 29
PANTOPRAZOLE SODIUM 489 480 20 44
PLAVIX 475 455 21 14
WARFARIN SODIUM 466 465 22 8
LEVOTHYROXINE SODIUM 457 457 23 22
ALPRAZOLAM 456 441 24 54
CLOPIDOGREL 392 377 25 10
SOTALOL 357 356 26 33
ISOSORBIDE MONONITRATE ER 357 356 26 16
SYNTHROID 357 357 26 64
LISINOPRIL-HYDROCHLOROTHIAZIDE 352 348 29 39
ALLOPURINOL 343 343 30 59
HYDRALAZINE HCL 339 335 31 47
METOPROLOL TARTRATE 339 325 31 4
VERAPAMIL ER 314 313 33 77
NITROSTAT 308 289 34 26
DIGOXIN 294 294 35 15
DIOVAN 289 289 36 21
TRIAMTERENE-HCTZ 280 268 37 53
CITALOPRAM HBR 260 260 38 67
BENICAR HCT 241 241 39 78
TAMSULOSIN HCL 237 228 40 62
POTASSIUM CHLORIDE 235 219 41 19
DONEPEZIL HCL 228 228 42 58
TRAMADOL HCL 222 222 43 65
DIOVAN HCT 210 205 44 35
BENICAR 210 199 44 69
TEMAZEPAM 199 199 46 73
ALENDRONATE SODIUM 198 197 47 60
METOLAZONE 191 180 48 135
ZOLPIDEM TARTRATE 190 190 49 32
PAROXETINE HCL 189 189 50 99
FINASTERIDE 186 186 51 110
MECLIZINE HCL 178 178 52 90
NADOLOL 177 171 53 112
RAMIPRIL 173 165 54 25
AMLODIPINE BESYLATE-BENAZEPRIL 163 150 55 46
FAMOTIDINE 153 143 56 66
BISOPROLOL-HYDROCHLOROTHIAZIDE 152 152 57 122
FENOFIBRATE 151 149 58 42
FELODIPINE ER 145 145 59 183
GLIMEPIRIDE 142 140 60 101
NAMENDA 140 140 61 80
CLONIDINE HCL 134 134 62 34
ENALAPRIL MALEATE 134 134 62 28
FLUOXETINE HCL 133 133 64 156
LANSOPRAZOLE 131 131 65 127
PRADAXA 131 124 65 23
CLORAZEPATE DIPOTASSIUM 130 130 67 163
GLIPIZIDE 123 123 68 94
FLUTICASONE PROPIONATE 121 121 69 98
LIPITOR 119 114 70 38
DOXAZOSIN MESYLATE 116 116 71 48
NEXIUM 113 107 72 41
SINGULAIR 112 112 73 102
ADVAIR DISKUS 111 111 74 84
KETOCONAZOLE 105 101 75 136
FOLIC ACID 98 98 76 150
COUMADIN 97 97 77 68
SERTRALINE HCL 97 97 77 74
NAPROXEN 97 97 77 120
BISOPROLOL FUMARATE 97 97 77 51
RANEXA 95 94 81 40
AMIODARONE HCL 89 89 82 30
VOLTAREN 88 88 83 106
AVODART 87 87 84 166
GABAPENTIN 86 86 85 57
NIFEDIPINE ER 81 81 86 43
DILTIAZEM ER 79 79 87 123
BENAZEPRIL HCL 79 79 87 85
VYTORIN 78 78 89 97
BUTALBITAL-ACETAMINOPHEN-CAFFE 78 78 R 89 300
TRIAMCINOLONE ACETONIDE 70 59 91 178
ACTOS 70 62 91 147
LORAZEPAM 68 61 93 115
AZITHROMYCIN 67 64 94 63
PRILOSEC OTC 66 66 95 320
LACTULOSE 65 65 96 155
GLYBURIDE 65 65 R 96 109
IBUPROFEN 65 65 96 70
INDAPAMIDE 64 64 99 118
LANTUS 63 63 100 114
MELOXICAM 62 62 101 88
MICARDIS HCT 60 60 102 139
ACTONEL 59 59 103 160
MULTAQ 59 51 103 56
PREDNISONE 58 58 105 100
NITROGLYCERIN PATCH 57 57 106 55
POLYETHYLENE GLYCOL 3350 56 56 107 209
LATANOPROST 56 56 107 191
GLYBURIDE-METFORMIN HCL 54 44 R 109 111
JANUVIA 54 54 109 104
CIALIS 53 42 111 219
PROAIR HFA 53 53 111 125
NIASPAN 51 51 113 50
CARTIA XT 51 51 113 76
CLONAZEPAM 50 45 115 188
BUSPIRONE HCL 50 50 115 208
GENERLAC 50 50 115 261
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 6, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.